Innovation Pharmaceuticals Receives New Brilacidin Patent, Further Expanding Intellectual Property Estate GlobeNewswire
BEVERLY, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, …